Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 7/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | GLA | P06280 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | FPR2 | P25090 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ramifenazone SCHEMBL3759490 | 0.98 | KDM4E (0.97) | KDM4ECYP1A2CYP2D6GAAKMT2A | |
| Ramifenazone SCHEMBL1652276 | 0.97 | KDM4E (0.94) | KDM4ECYP1A2CYP2D6GAAKMT2A | |
| SCHEMBL537958 | 0.82 | KDM4E (0.69) | KDM4ECYP1A2CYP2D6GAAKMT2A | |
| SCHEMBL8651089 | 0.81 | KDM4E (0.68) | KDM4ECYP1A2CYP2D6GAAKMT2A | |
| SCHEMBL18000055 | 0.81 | KDM4E (0.68) | KDM4ECYP1A2CYP2D6GAAKMT2A | |
| SCHEMBL4447238 | 0.81 | KDM4E (0.68) | KDM4ECYP1A2CYP2D6GAAKMT2A | |
| Magnesium SCHEMBL29732237 | 0.81 | KDM4E (0.68) | KDM4ECYP1A2CYP2D6GAAKMT2A | |
| SCHEMBL8940124 | 0.81 | KDM4E (0.68) | KDM4ECYP1A2CYP2D6GAAKMT2A | |
| SCHEMBL28880300 | 0.79 | TSHR (0.81) | KDM4EGAAKMT2ALMNATSHR | |
| SCHEMBL10595695 | 0.79 | GAA (0.77) | KDM4ECYP1A2CYP2D6GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2707 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240041935-A1 | PREVENTION AND TREATMENT OF REPRODUCTIVE FAILURE BY REGENERATIVE CELLS AND ADJUVANTS | CREATIVE MEDICAL TECHNOLOGIES, INC. (US) | 2024-02-08 | — | — | US | claimed |
| CN-117110493-A | Metabolic marker associated with neonatal pneumonia and metabolic acidosis and application thereof | 大连大学 | 2023-11-24 | — | — | CN | claimed |
| US-11819535-B2 | Composition and methods for regulating extracellular matrix accumulation | UNIVERSITY HEALTH NETWORK (CA) | 2023-11-21 | — | — | US | claimed |
| CN-116893237-A | Metabolic marker related to neonatal pneumonia and myocardial damage and application thereof | 大连大学 | 2023-10-17 | — | — | CN | claimed |
| US-11771695-B2 | Cannabinoid receptor modulators | ARENA PHARMACEUTICALS, INC. (US) | 2023-10-03 | — | — | US | claimed |
| US-11608532-B2 | Precision medicine for treating and preventing suicidality | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2023-03-21 | — | — | US | claimed |
| EP-3385252-B1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARM INC (US) | 2022-09-21 | — | — | EP | claimed |
| US-20220241274-A1 | CANNABINOID RECEPTOR MODULATORS | ARENA PHARMACEUTICALS, INC. | 2022-08-04 | — | — | US | claimed |
| US-10991449-B2 | Predicting suicidality using a combined genomic and clinical risk assessment | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2021-04-27 | — | — | US | claimed |
| US-20200318188-A1 | PRECISION MEDICINE FOR TREATING AND PREVENTING SUICIDALITY | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2020-10-08 | — | — | US | claimed |
| WO-2000042050-A1 | SULFATED PHOSPHATIDYLINOSITOLS, THEIR PREPARATION AND USE | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2000-07-20 | — | — | WO | claimed |
| US-6063370-A | DRUG, POLYMER COMPLEX | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2000-05-16 | — | — | US | claimed |
| EP-0786999-A4 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO INC (US) | 1999-01-20 | — | — | EP | claimed |
| EP-0792371-A4 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO INC (US) | 1998-12-30 | — | — | EP | claimed |
| WO-1997037680-A1 | MACROMOLECULAR COMPLEXES FOR DRUG DELIVERY | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1997-10-16 | — | — | WO | claimed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |